The 5:2 method: what the trials report

The 5:2 method (popularised in the UK by Michael Mosley and Mimi Spencer's 2013 book) prescribes two non-consecutive days per week of ~500 kcal (women) or 600 kcal (men), with normal eating on the other five days. It's one of the better-studied intermittent fasting patterns.

Why people choose it#

The behavioural appeal is the asymmetry. Most of the week you don't think about fasting at all. Two days a week you tolerate a deliberately low intake. That distribution suits people who hate daily restriction and prefer occasional discipline.

It's also more flexible than alternate-day fasting and easier to socialise around than time-restricted eating.

What the trials show#

Multiple RCTs have compared 5:2 to standard daily calorie restriction with matched weekly intake:

• Harvie et al. 2011: premenopausal women with overweight; intermittent restriction (similar to 5:2) produced greater reductions in fat mass, fasting insulin, and insulin resistance than daily restriction over 6 months.
• Carter et al. 2018: adults with type 2 diabetes; 5:2 produced HbA1c reductions equivalent to daily caloric restriction over 12 months. Significantly, 5:2 was easier to adhere to.
• Schübel et al. 2018 — 5:2 vs. daily restriction in non-diabetic adults; similar weight loss; no clear metabolic advantage for either.

The pattern across trials: 5:2 produces comparable weight and metabolic outcomes to daily restriction when total weekly calories are matched. Some trials suggest adherence is better with 5:2.

What the fast days actually look like#

In Mosley's original protocol, fast-day eating was concentrated in 1–2 modest meals. Practical patterns that work:

• Skip breakfast; have a moderate lunch and very small dinner totalling ~500 kcal
• Eat 1–2 protein-rich, lower-carbohydrate meals
• Hydrate aggressively: water, black coffee, plain tea

Most people report feeling hungrier in the first 2–3 weeks; the subjective difficulty drops as patterns establish.

What the 5 normal days should look like#

A common mistake: treating non-fast days as eating-license. Trial data is for normal non-fast days, not compensatory overeating. People who overeat substantially on non-fast days don't get the trial outcomes.

The boring honest message: 5:2 is a tool for moderate caloric deficit. The other 5 days should look like sensible food, not feast.

Hormonal and metabolic effects#

Most fast-day biology is similar to a longer fast:

• Insulin drops sharply
• Glucose dips modestly (often not symptomatically)
• Cortisol may rise transiently
• Ghrelin (hunger hormone) climbs across the first 2–3 weeks then often stabilises

These are all transient and resolve on normal eating days.

Who should be cautious#

Same population as other fasting protocols:

• Pregnancy or breastfeeding
• History of disordered eating
• Type 1 diabetes or insulin/sulfonylurea users without clinical input
• BMI ≤18.5 or unintentional weight loss
• Active eating disorder or risk of one

What we'd actually say#

For someone with overweight or insulin resistance who finds daily restriction unsustainable, 5:2 is a reasonable evidence-based pattern with comparable outcomes to daily restriction. The adherence advantage is real for many people.

For someone whose main issue is body composition with normal metabolic markers, daily moderate-calorie eating with adequate protein and regular resistance training does most of the work. Adding 5:2 is a tool, not a foundation.

When to talk to a clinician#

• Type 2 diabetes on medication (especially sulfonylureas): fast-day doses may need adjustment
• On medications taken with food (some antibiotics, NSAIDs)
• Pregnancy or breastfeeding
• History of disordered eating
• Persistent dizziness, headaches, or syncope on fast days